Actuate Therapeutics, Inc.
ACTU
$5.96
$0.142.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.05% | 192.07% | -- | -- | -89.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 199.83% | 1,434.69% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 94.17% | 207.38% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 94.17% | 207.38% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -54.06% | -- | -- | -- | -- |
| Total Assets | 66.12% | 211.07% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -33.16% | -43.85% | -- | -- | -- |
| Total Accrued Expenses | 12.67% | 96.68% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -37.87% | 27.19% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -37.87% | 27.19% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -22.83% | -23.03% | -- | -- | -- |
| Total Liabilities | -37.34% | 23.59% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 2,278.99% | 2,322.90% | -- | -- | -- |
| Retained Earnings | -22.32% | -25.96% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 95.28% | 100.10% | -- | -- | -43.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 4.67% |
|
|
|||||
| Total Common Equity | 95.28% | 100.10% | -- | -- | -43.12% |
| Total Preferred Equity | -- | -- | -- | -- | 4.67% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.54% | 102.34% | -- | -- | -180.37% |
|
|
|||||